These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 32436944)
1. Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics. Jiang Y; He Q; Zhang T; Xiang W; Long Z; Wu S Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436944 [TBL] [Abstract][Full Text] [Related]
2. Network Pharmacology-Based Strategy Reveals the Effects of Zhang S; Yuan Z; Wu H; Li W; Li L; Huang H Biomed Res Int; 2020; 2020():8260703. PubMed ID: 33134388 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of Danxiong Tongmai Granules in treatment of coronary heart disease. Ye J; Yang R; Li L; Zhong S; Jiang R; Hu Z Aging (Albany NY); 2024 May; 16(10):8843-8865. PubMed ID: 38775721 [TBL] [Abstract][Full Text] [Related]
4. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning. Yang J; Tian S; Zhao J; Zhang W Pharmacol Res; 2020 Sep; 159():105034. PubMed ID: 32565312 [TBL] [Abstract][Full Text] [Related]
5. Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases. Li G; Xu Q; Han K; Yan W; Huang C Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32990315 [TBL] [Abstract][Full Text] [Related]
6. Exploration of the molecular targets and mechanisms of suxiao xintong dropping pills for myocardial infarction by network pharmacology method. Chen D; Wu Y; Chen Y; Chen Q; Ye X; Xu S; Luo S Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34286341 [TBL] [Abstract][Full Text] [Related]
7. The Effect of Yang K; Zeng L; Ge A; Shi Y; Zhu X; Liu W; Ge J Oxid Med Cell Longev; 2020; 2020():6072380. PubMed ID: 33082911 [TBL] [Abstract][Full Text] [Related]
8. A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke. Cui Q; Zhang YL; Ma YH; Yu HY; Zhao XZ; Zhang LH; Ge SQ; Zhang GW; Qin XD J Ethnopharmacol; 2020 Jul; 257():112891. PubMed ID: 32315738 [TBL] [Abstract][Full Text] [Related]
9. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network. Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of Baihe Decoction in the treatment of coronary heart disease based on network pharmacology and molecular docking. Jin Y; Yin X; Li Z; Xu J Ann Palliat Med; 2021 Mar; 10(3):3205-3218. PubMed ID: 33849106 [TBL] [Abstract][Full Text] [Related]
11. Exploring the mechanism of Danggui Buxue Decoction in regulating atherosclerotic disease network based on integrated pharmacological methods. Xu H; Zhang T; He L; Yuan M; Yuan X; Wang S Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34528665 [TBL] [Abstract][Full Text] [Related]
12. Integrating network pharmacology and experimental evidence to decipher the cardioprotective mechanism of Yiqihuoxue decoction in rats after myocardial infarction. Li FH; Guo SW; Zhan TW; Mo HR; Chen X; Wang H; Wei LL; Feng PF; Wu JG; Li P J Ethnopharmacol; 2021 Oct; 279():114062. PubMed ID: 33771641 [TBL] [Abstract][Full Text] [Related]
13. Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury. Zhao Y; Zhang X; Luan J; Zhao B; An N; Sun N; Wang X; Zhao T; Sun Y; Fu ZD; Zhang Y; Zhang Y Cell Physiol Biochem; 2018; 48(6):2503-2516. PubMed ID: 30121659 [TBL] [Abstract][Full Text] [Related]
14. Prediction the Molecular Mechanism of Shengmai Injection in Acute Treatment of COVID-19 Based on Network Pharmacology. Wang C; Liu AL; Wu HZ; Yang YF Nat Prod Commun; 2022 Feb; 17(2):1934578X221075075. PubMed ID: 35136386 [No Abstract] [Full Text] [Related]
15. Network pharmacology-based therapeutic mechanism of Kuanxiong aerosol for angina pectoris. Wu B; Wang G; Xin L; Li Q; Lu X; Su Y; Huang P J Ethnopharmacol; 2020 Oct; 261():113079. PubMed ID: 32526337 [TBL] [Abstract][Full Text] [Related]
16. Shengmai Yin formula exerts cardioprotective effects on rats with chronic heart failure via regulating Linoleic Acid metabolism. Wang S; Gan J; Li J; Wang Y; Zhang J; Song L; Yang Z; Guo M; Jiang X Prostaglandins Other Lipid Mediat; 2022 Feb; 158():106608. PubMed ID: 34958945 [TBL] [Abstract][Full Text] [Related]
17. Exploring the mechanism of action Xianlingubao Prescription in the treatment of osteoporosis by network pharmacology. Zhu N; Hou J Comput Biol Chem; 2020 Apr; 85():107240. PubMed ID: 32126522 [TBL] [Abstract][Full Text] [Related]
18. Identification of the active compounds and drug targets of Chinese medicine in heart failure based on the PPARs-RXRα pathway. Shao M; Guo D; Lu W; Chen X; Ma L; Wu Y; Zhang X; Wang Q; Wang X; Li W; Wang Q; Wang W; Li C; Wang Y J Ethnopharmacol; 2020 Jul; 257():112859. PubMed ID: 32294506 [TBL] [Abstract][Full Text] [Related]
19. Network pharmacology-based prediction of the active ingredients and mechanism of Shen Gui capsule for application to coronary heart disease. Wang D; Tian L; Shi C; Wei YX; Wang H; Liu TT; Gong M; Zhang YW; Yu RG; Wu XH Comput Biol Med; 2020 Jul; 122():103825. PubMed ID: 32658730 [TBL] [Abstract][Full Text] [Related]
20. Integrating systematic biological and proteomics strategies to explore the pharmacological mechanism of danshen yin modified on atherosclerosis. Yang K; Zeng L; Ge A; Pan X; Bao T; Long Z; Tong Q; Yuan M; Zhu X; Ge J; Huang Z J Cell Mol Med; 2020 Dec; 24(23):13876-13898. PubMed ID: 33140562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]